Valuation Ipsen

Stocks

Real-time Euronext Paris 18:56:40 26/08/2026 HKT			5-day change	1st Jan Change
165.70 ^EUR	-0.18%		+0.36%	+39.24%

08-21	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI
08-21	Ipsen Wraps Up Purchase of US-based Kartos Therapeutics	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,610	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	39.31%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	12,372	11,311	10,501
Change	-	16.81%	12.22%	1.81%	2.28%	34.11%	-8.58%	-7.16%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13.8x	14.1x	14.2x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.66x	2.26x	1.96x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-6.33x	-23.59x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	3x	2.94x	2.81x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.72x	2.44x	2.17x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.54x	6.37x	5.86x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.47x	7.5x	7.03x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.59x	9.3x	8.54x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.4%	10.8%	11.7%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.92%	0.92%	1%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.02	11.75	11.68
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13%	14.2%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,543	4,637	4,840
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,893	1,776	1,792
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,656	1,508	1,494
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,011	985.4	981.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,238	-2,299	-3,109
Reference price ²	80.50	100.50	107.90	110.70	119.00	166.00	166.00	166.00
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	13.81x	2.72x	6.54x	0.92%	15.88B
ELI LILLY AND COMPANY	35.12x	12.73x	25.81x	0.56%	1,100B
JOHNSON & JOHNSON	30.38x	-	-	1.97%	658B
ABBVIE INC.	33.92x	7.84x	16.3x	2.58%	470B
ROCHE HOLDING AG	20.83x	4.94x	12.23x	2.67%	372B
NOVARTIS AG	22.71x	5.84x	14.47x	2.73%	304B
ASTRAZENECA PLC	21.88x	4.48x	12.79x	1.96%	264B
AMGEN INC.	27.97x	7.21x	12.8x	2.28%	239B
NOVO NORDISK A/S	13.99x	4.96x	10.35x	3.67%	213B
GILEAD SCIENCES, INC.	-45.46x	6.56x	25.6x	2.22%	184B
Average	17.52x	6.36x	15.21x	2.16%	381.88B
Weighted average by Cap.	25.26x	8.39x	18.49x	1.89%